First City Capital Management, Inc. Haleon PLC Transaction History

First City Capital Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 26, 2023	SELL	$7.85 - $8.94 $918 - $1,045	-117 Reduced 0.72%	16,210 $135,000
Q2 2023 Jul 19, 2023	SELL	$8.04 - $9.0 $51,986 - $58,194	-6,466 Reduced 28.37%	16,327 $136,000
Q1 2023 May 01, 2023	SELL	$7.57 - $8.37 $1,900 - $2,100	-251 Reduced 1.09%	22,793 $185,000
Q4 2022 Feb 13, 2023	SELL	$5.96 - $8.06 $8,344 - $11,284	-1,400 Reduced 5.73%	23,044 $184,000
Q3 2022 Oct 24, 2022	BUY	$5.63 - $7.5 $137,619 - $183,330	24,444 New	24,444 $149,000

639

412M

149K

16K

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $44.8B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

Get notified when there are updates to the investment portfolio of First City Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on First City Capital Management, Inc. with notifications on news.